Operating Lease, Right-of-Use Asset of Singular Genomics Systems, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Singular Genomics Systems, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2024.
  • Singular Genomics Systems, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $42,617,000, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Singular Genomics Systems, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $42,617,000 -$15,857,000 -27% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $56,381,000 +$12,517,000 +29% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $57,094,000 +$12,221,000 +27% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $57,797,000 +$11,901,000 +26% 31 Dec 2023 10-Q 12 Nov 2024 2024 Q3
Q3 2023 $58,474,000 +$11,579,000 +25% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $43,864,000 -$4,381,000 -9.1% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $44,873,000 +$39,124,000 +681% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $45,896,000 +$45,896,000 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $46,895,000 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $48,245,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $5,749,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 02 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.